Your browser doesn't support javascript.
loading
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
Pishvaian, Michael J; Slack, Rebecca S; Jiang, Wei; He, A Ruth; Hwang, Jimmy J; Hankin, Amy; Dorsch-Vogel, Karen; Kukadiya, Divyesh; Weiner, Louis M; Marshall, John L; Brody, Jonathan R.
Afiliación
  • Pishvaian MJ; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Slack RS; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jiang W; Carolinas Medical Center, Charlotte, North Carolina.
  • He AR; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Hwang JJ; Carolinas Medical Center, Charlotte, North Carolina.
  • Hankin A; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Dorsch-Vogel K; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Kukadiya D; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Weiner LM; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Marshall JL; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Brody JR; Jefferson Pancreas, Biliary, and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Cancer ; 124(11): 2337-2346, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29579325
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bencimidazoles / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Temozolomida Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bencimidazoles / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Temozolomida Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article